CSIMarket Company Name, Ticker, Customers, else..
 
Scisparc Ltd  (NASDAQ: SPRC)
 
Price: $5.2900 $0.16 3.119%
Day's High: $5.434999942779541 Week Perf: -20.21 %
Day's Low: $ 5.15 30 Day Perf: -21.28 %
Volume (M): 27,399 52 Wk High: $ 80.10
Volume (M$): $ 0 52 Wk Avg: $12.98
Open: $5.17 52 Wk Low: $2.98



 Market Capitalization (Millions $) -
 Shares Outstanding (Millions) -
 Employees 25
 Revenues (TTM) (Millions $) 1
 Net Income (TTM) (Millions $) 13
 Cash Flow (TTM) (Millions $) 0
 Capital Exp. (TTM) (Millions $) 0

Business Description


Scisparc Ltd is a technology company that specializes in developing artificial intelligence solutions for the healthcare industry. The company's software and algorithms are designed to analyze complex medical data, provide insights, and assist medical professionals in making accurate diagnoses and treatment decisions. Scisparc's solutions aim to improve patient outcomes, reduce medical errors, and streamline healthcare processes. The company focuses on leveraging cutting-edge technologies like machine learning, natural language processing, and data analytics to deliver innovative and effective healthcare solutions.


   Company Address: 20 Raul Wallenberg St. Tel Aviv 6971916
   Company Phone Number: 3-7175777   Stock Exchange / Ticker: NASDAQ SPRC


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
ARDX   -0.79%    
CAPR   -1.98%    
CRMD        1.57% 
PRAX        2.05% 
RCUS        1.54% 
SBFM   -0.87%    
• View Complete Report
   



Partnership

In a landmark advancement within the pharmaceutical industry, the collaborative efforts of SciSparc Ltd. an...

Published Mon, Oct 20 2025 12:03 PM UTC

Innovative Collaboration in Pharmaceutical Research Sheds Light on Binge Behavior and Weight Loss Therapies In a landmark advancement within the pharmaceutical industry, the collaborative efforts of SciSparc Ltd. and Clearmind Medicine Inc. have culminated in the publication of a promising U.S. patent application. This development highlights the groundbreaking approach the t...
Announcement

SciSparcs Strategic Pivot Merging Pharmaceuticals with Automotive Innovation

Published Thu, Aug 28 2025 11:21 AM UTC

In a surprising turn of events, SciSparc Ltd. (Nasdaq: SPRC), traditionally a stalwart in the pharmaceutical sector focusing on central nervous system disorders, announced a monumental shift in its operational strategy with the approval of a merger with AutoMax Motors Ltd., a leading parallel vehicle importer in Israel. The decision, which was made during an adjourned specia...
Announcement

Crossing Frontiers SciSparcs Harmonious Merger of Medicine and Mobility,

Published Thu, Jul 31 2025 2:42 AM UTC

In the dynamic arena of pharmaceuticals and automotive imports, few companies have managed to capture the synergy and strategic foresight quite like SciSparc Ltd. (Nasdaq: SPRC). With its dual focus a profound legacy in central nervous system therapeutics and an unexpected yet trailblazing partnership in the electric vehicle sector SciSparc is demonstrating an innovative ble...
Contract

SciSparcs Transformational Journey Strategic Divestments, New Alliances, and Diversification,

Published Fri, Jun 20 2025 2:11 PM UTC

SciSparc Ltd. (Nasdaq: SPRC), an innovative clinical-stage pharmaceutical company dedicated to pioneering therapies for challenging central nervous system disorders, has been in the news for a series of significant strategic maneuvers aimed at strengthening its market position and broadening its operational sphere. These moves reflect a strategic pivot that might redefine it...
Announcement

SciSparc Expands Horizons Update on Spin-Off of Pharmaceutical Portfolio Valued at $11.6 Million

Published Sun, Dec 29 2024 8:24 PM UTC

In a strategic move that underscores its commitment to innovation and growth in the pharmaceutical sector, SciSparc Ltd. a biotechnology firm specializing in the development of advanced clinical-stage therapies, has provided crucial updates regarding the impending spin-off of its advanced pharmaceutical portfolio into a publicly traded company. This maneuver, detailed in a r...



Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) -
Price to Sales (Expected) -
Price to Book -
PEG (TTM) -

Financial Strength Current
Quick Ratio 2.04
Working Capital Ratio 2.41
Leverage Ratio (MRQ) 0.48
Total Debt to Equity 0.07
Interest Coverage (TTM) -
Debt Coverage (TTM) 35.29

Per Share Current
Earnings (TTM) 0 $
Revenues (TTM) -
Cash Flow (TTM) -
Cash -
Book Value -
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) 34,240
Net Income per Employee (TTM) 502,560
Receivable Turnover Ratio (TTM) 77.82
Inventory Turnover Ratio (TTM) -
Asset Turnover Ratio (TTM) 0.12

Profitability Ratios Current
Gross Margin (MRQ) 73.71 %
Operating Margin (MRQ) 978.27 %
Net Margin (MRQ) 1467.76 %
Net Cash Flow Margin (MRQ) 0 %
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) 179.45 %
Return On Investment (TTM) 309.31 %
Return On Equity (TTM) 327.19 %
Dividend Yield -
Pay out Ratio (TTM) -



Scisparc Ltd's Segments





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.